Showing results (1821-1830 of 6,770) with videos related to
Sort By:
Pageof 677
Clinical Therapeutics|July 29, 2023
Defining Need Amid Exponential Change: Conceptual Challenges in Workforce Planning for Clinical Genetic ServicesKennedy Borle, Nicola Kopac, Nick Dragojlovic, et al.Clinical Therapeutics|March 15, 2003
The impact of nonsteroidal anti-inflammatory drugs on blood pressure, with an emphasis on newer agentsEdward P Armstrong, Daniel C MaloneClinical Therapeutics|March 15, 2003
Effect of amlodipine on systolic blood pressureCindy B Levine, Kyle R Fahrbach, Diana Frame, et al.Clinical Therapeutics|March 15, 2003
Gabapentin dosing for neuropathic pain: evidence from randomized, placebo-controlled clinical trialsMiroslav Backonja, Robert L GlanzmanClinical Therapeutics|March 15, 2003
An examination of the results of the EVIDENCE, INCOMIN, and phase III studies of interferon beta products in the treatment of multiple sclerosisTimothy VartanianClinical Therapeutics|March 15, 2003
Activity of nine oral agents against gram-positive and gram-negative bacteria encountered in community-acquired infections: use of pharmacokinetic/pharmacodynamic breakpoints in the comparative assessment of beta-lactam and macrolide antimicrobial agentsMihaela Peric, Frederick A Browne, Michael R Jacobs, et al.Clinical Therapeutics|March 15, 2003
An economic assessment of inhaled formoterol dry powder versus ipratropium bromide pressurized metered dose inhaler in the treatment of chronic obstructive pulmonary diseaseThomas J Hogan, Rick Geddes, Edgar R GonzalezClinical Therapeutics|March 15, 2003
A 3-stage model for assessing the probable economic effects of direct-to-consumer advertising of pharmaceuticalsRonald J Vogel, Sulabha Ramachandran, Woodie M ZachryClinical Therapeutics|October 17, 2002
Durability of efficacy and long-term safety profile of glyburide/metformin tablets in patients with type 2 diabetes mellitus: an open-label extension studyAlan J Garber, Simon Bruce, Fred T FiedorekClinical Therapeutics|December 5, 2002
The abacavir hypersensitivity reaction: a reviewPatrick G ClayPageof 677